An mHealth Intervention to Improve HIV Prevention Service Engagement Among People Who Use Drugs

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorUniversity of California, San Diego

About this trial

The goal of this single arm pre-post study is to assess the feasibility, acceptability, and preliminary impact of the LOTUS intervention to improve HIV prevention service engagement among people who use drugs. LOTUS is a technology-delivered intervention that provides HIV prevention informational content and tips, peer social support and social networking features, a resource locator, HIV prevention monitoring and reminders (e.g., reminders for HIV/STI testing and PrEP doses), and a virtual space to have questions answered by health care professionals.

Eligibility criteria

Qualifiers

18 years of age or older

Report weekly or daily use of opioids and/or stimulants in the past 6 months

Meet current CDC eligibility criteria for PrEP

Report low levels of HIV prevention service engagement in the past 6 months

Disqualifiers

17 years of age or younger

Does not report weekly or daily use of opioids and/or stimulants in the past 6 months

Does not meet current CDC eligibility criteria for PrEP

Report high levels of HIV prevention service engagement in the past 6 months

Trial design

Treatments tested in this trial

  • LOTUS mHealth Intervention Group

Treatment groups

40 Participants
are divided into 1 treatment group

Sponsors and collaborators

University of California, San Diego

Lead sponsor

National Institute on Drug Abuse (NIDA)

Collaborator